Aaron Weitzman / Axios:

Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight  —  PhaseV, a clinical trial and development software startup, raised a $50 million Series A, CEO Raviv Pryluk tells Axios exclusively.

Aaron Weitzman / Axios:

Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight  —  PhaseV, a clinical trial and development software startup, raised a $50 million Series A, CEO Raviv Pryluk tells Axios exclusively.

Source: TechMeme
Source Link: http://www.techmeme.com/250517/p3#a250517p3